Interviews
News Flash
Bilcare buys out Singular ID
08 Jan '08
3 min read
Bilcare has publicized its interest in anti-counterfeiting technology previously, having developed a number of packaging solutions in house and formed strategic alliances with companies.
However, this acquisition underlines the importance that Bilcare places on offering state-of-the-art anti-counterfeiting solutions, particularly fully integrated systems such as Singular ID's enxure product. It also indicates how important the issues of brand protection are to the pharmaceutical
and medical industry.
Dr Peter Moran comments, “We have already been interacting with Bilcare's technical teams in both Singapore and India and can see great potential and synergy arising from this transaction. Bilcare brings important manufacturing experience that will help us to quickly scale up our production to meet the requirements of very high volume, very low item cost, and yet robust security.
As we achieve this for pharmaceutical applications, we will be able to apply this to our other target sectors and provide an even more competitive product.”
Joining the Board of Singular ID will be Dr Rahul Bharadia, Director of Research at Bilcare Singapore, Mr Vineet Mehrotra, Vice President (Finance) of Bilcare, and Mr Mohan H. Bhandari the Chairman and Managing Director of Bilcare.
“With counterfeit medicines affecting the safety of the consumer as well as damaging the reputation and bottom line of the pharmaceutical industry, there is a realneed for a scalable and robust solution. I am delighted to have brought Singular ID into the Bilcare group and to add the enxure system to our future product line”, explained Mr Bhandari.
However, this acquisition underlines the importance that Bilcare places on offering state-of-the-art anti-counterfeiting solutions, particularly fully integrated systems such as Singular ID's enxure product. It also indicates how important the issues of brand protection are to the pharmaceutical
and medical industry.
Dr Peter Moran comments, “We have already been interacting with Bilcare's technical teams in both Singapore and India and can see great potential and synergy arising from this transaction. Bilcare brings important manufacturing experience that will help us to quickly scale up our production to meet the requirements of very high volume, very low item cost, and yet robust security.
As we achieve this for pharmaceutical applications, we will be able to apply this to our other target sectors and provide an even more competitive product.”
Joining the Board of Singular ID will be Dr Rahul Bharadia, Director of Research at Bilcare Singapore, Mr Vineet Mehrotra, Vice President (Finance) of Bilcare, and Mr Mohan H. Bhandari the Chairman and Managing Director of Bilcare.
“With counterfeit medicines affecting the safety of the consumer as well as damaging the reputation and bottom line of the pharmaceutical industry, there is a realneed for a scalable and robust solution. I am delighted to have brought Singular ID into the Bilcare group and to add the enxure system to our future product line”, explained Mr Bhandari.
Singular ID Pte Ltd
Popular News
Leave your Comments
C Devarajan & P Raajashekar
Texvalley
Andreas Rass
ZIMMER AUSTRIA | Digital Printing Systems
Ata Turgutalp
Eliar Elektronik San. A.S.
Esteemed Clients
-Ltd..jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Thermore (Far East) Ltd.")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Telangana State Industrial Infrastructure Corporation Limited (TSllC Ltd)")
.jpg?tr=w-120,h-60,c-at_max,cm-pad_resize,bg-ffffff "Taiwan Textile Federation (TTF)")
